# Levofloxacin Concomitant Versus Levofloxacin Sequential

> **NCT06065267** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Damascus Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** sequential
- **DRUG:** Levofloxacin 500Mg Oral Tablet

## Key facts

- **NCT ID:** NCT06065267
- **Lead sponsor:** Damascus Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06065267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06065267, "Levofloxacin Concomitant Versus Levofloxacin Sequential". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06065267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*